Skip to content
by Legal Desire
Lawyer profile

Judith Hasko

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
corporate, corporate and collaboration matters, general corporate
Office
Bay Area, Silicon Valley
Active in the record
2020 to 2024

Deal experience

Recent deals

14 announced deals in the record
Latham & Watkins Advises Allogene Therapeutics in Pricing of US$110 Million Offering of Common Stock 17 May 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 110m IP Bay Area
Latham & Watkins Advises Goldman Sachs Asset Management in US$150 Million Series B Funding for Rapport Therapeutics 2 Nov 2023
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 150m IP Silicon Valley
Latham & Watkins Advises Sonoma Biotherapeutics in Collaboration with Regeneron Pharmaceuticals 29 Mar 2023
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP Lead licensing Bay Area
Latham & Watkins Advises Imago BioSciences in Acquisition by Merck for US$1.35 Billion 23 Nov 2022
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.35bn intellectual property Bay Area
Latham Represents CytomX in Collaboration and Licensing Agreement With Regeneron Pharmaceuticals 18 Nov 2022
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP Lead corporate Bay Area
Latham & Watkins Advises Orbital Therapeutics in Strategic Partnership With Beam Therapeutics and Initial Funding 27 Oct 2022
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP Lead corporate and collaboration matters Bay Area
Latham & Watkins Advises Homology Medicines, Inc. in a Newly Formed AAV Manufacturing and Innovation Business with Oxford Biomedica 31 Jan 2022
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP USD 130m Lead licensing
Latham & Watkins Advises Itamar Medical in Acquisition by ZOLL Medical 13 Sept 2021
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 538m intellectual property Bay Area
Latham & Watkins Advises Imago BioSciences on its Upsized Initial Public Offering 21 Jul 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 134m intellectual property Bay Area
Latham & Watkins Advises the Underwriters in Lyell Immunopharma’s US$425 Million IPO 17 Jun 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 425m intellectual property matters Bay Area
Deal alerts PRO

Get an email when Judith Hasko is named on a newly announced deal.

Alerts come as one daily email at most.

Pro

See all 14 deals for Judith Hasko

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction